Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.0M
Net Open-Market Flow
-$5.0M
Transactions
11
10 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2026Option exercise(M)10K$135.42$1.3M50K
Jul 14, 2026Sell(S)840$524.15$440K49K
Jul 14, 2026Sell(S)1K$525.16$771K48K
Jul 14, 2026Sell(S)3K$526.13$1.8M44K
Jul 14, 2026Sell(S)1K$527.06$643K43K
Jul 14, 2026Sell(S)660$528.13$349K42K
Jul 14, 2026Sell(S)959$529.21$508K41K
Jul 14, 2026Sell(S)554$530.67$294K41K
Jul 14, 2026Sell(S)107$531.08$57K41K
Jul 14, 2026Sell(S)200$532.60$107K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2026Option exercise(M)10K$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000098) within minutes of acceptance. Every field above traces to the original document. Verify it directly: